Programmdetails

Keynote Session

Gene Therapy in cardiovascular disease: Where are we?

Freitag, 5. April | 11:15 - 12:45 Uhr | Saal 14

Vorsitz/Chair: Stefan Engelhardt (München), Laura Zelarayán (Göttingen)

/content/dam/herzmedizin/congresses/shared/icon_en.png

Agenda

11:15
(V1372)
The generation of a novel viral expression system for the in-vitro modelling of viral myocarditis
S. Peischard (Münster)
11:25
Discussion
11:30
(V1373)
Optogenetic investigation of myocytes and non-myocytes in cardiac remodeling
C. F. Marbely del Carmen (Freiburg im Breisgau)
11:40
Discussion
11:45
(V1374)
Pleiotropic effects of AAV.SERCA2a treatment for heart failure in DMD pigs
I. Luksch (München)
11:55
Discussion
12:00
(V1375)
Effect of CRE-AAV excision of the rescue cassette in a pig model of PLN
C. Cabrera-Gomez (München)
12:10
Discussion
12:15
(V1376)
Keynote Lecture: Gene therapy and HCM – Are we there yet?
L. Carrier (Hamburg)
12:35
Discussion
13:00 - 14:00

DGK-General Assembly part 1 in hall 4

Diese Seite teilen